Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 24566-81-2 | MDL No. : | MFCD07780174 |
Formula : | C4H11Br2N | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PZKCNXZSEAHUGH-UHFFFAOYSA-N |
M.W : | 232.94 | Pubchem ID : | 24189510 |
Synonyms : |
|
Num. heavy atoms : | 7 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 41.96 |
TPSA : | 26.02 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.32 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 1.97 |
Log Po/w (WLOGP) : | 2.08 |
Log Po/w (MLOGP) : | 1.89 |
Log Po/w (SILICOS-IT) : | 0.9 |
Consensus Log Po/w : | 1.37 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.33 |
Solubility : | 1.1 mg/ml ; 0.00471 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.14 |
Solubility : | 1.68 mg/ml ; 0.00721 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.98 |
Solubility : | 2.47 mg/ml ; 0.0106 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.22 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
5.387 g | With dmap; di-<i>tert</i>-butyl dicarbonate; triethylamine In dichloromethane at 20℃; for 1.5 h; | The 5 g 4 - the bromine is positive butane -1 - ammonia hydrobromide with 4.686 g (1.5 eq) carbonic acid di-tert-butyl dicarbonate dissolved in two in the methylene chloride solution, stirring and dissolving, slowly dropping containing 193 mg (0.1 eq) 4 - dimethylamino pyridine and 8.688 g (4 eq) methylene dichloride solution of triethylamine, the reaction at room temperature for 1.5 h. Finally in the separatory funnel for respectively 0.5 N hydrochloric acid aqueous solution and saturated salt water washing the reaction solution, after drying by anhydrous sodium sulfate, filtered, reduced pressure distillation to remove the organic solvent, to obtain 5.387 g intermediate II. |
[ 365432-20-8 ]
4-Bromo-N-methylbutan-1-amine hydrobromide
Similarity: 0.82
[ 5003-71-4 ]
3-Bromopropan-1-amine hydrobromide
Similarity: 0.73
[ 365432-20-8 ]
4-Bromo-N-methylbutan-1-amine hydrobromide
Similarity: 0.82
[ 5003-71-4 ]
3-Bromopropan-1-amine hydrobromide
Similarity: 0.73
[ 99337-81-2 ]
4-Bromocyclohexanamine hydrochloride
Similarity: 0.67
[ 365432-20-8 ]
4-Bromo-N-methylbutan-1-amine hydrobromide
Similarity: 0.82
[ 5003-71-4 ]
3-Bromopropan-1-amine hydrobromide
Similarity: 0.73
[ 99337-81-2 ]
4-Bromocyclohexanamine hydrochloride
Similarity: 0.67
[ 333-93-7 ]
1,4-Diaminobutane dihydrochloride
Similarity: 0.60
[ 6055-52-3 ]
Hexane-1,6-diamine dihydrochloride
Similarity: 0.56